Keyphrases
COVID-19
100%
Alzheimer's Disease
70%
Confidence Interval
63%
Older Adults
59%
Lung Transplantation
44%
United States
43%
Virus
43%
Sepsis
43%
Parkinson's Disease
40%
Risk Factors
39%
West Nile Virus
32%
Lung
31%
T Cells
30%
AIDS/HIV
28%
Odds Ratio
28%
Emergency Department
27%
Dendritic Cells
27%
Macrophages
27%
Monoclonal Antibody
27%
Cerebrospinal Fluid
25%
Heart Failure
25%
Clinical Trials
25%
Randomized Controlled Trial
24%
Inflammation
23%
Clinical Outcomes
22%
Pediatric
20%
Comorbidity
20%
Gene Expression
20%
Antibiotics
20%
Immune Response
19%
People Living with HIV (PLHIV)
19%
High Risk
19%
West Nile Virus Infection
19%
Interferon-α (IFN-α)
19%
Intensive Care Unit
18%
St. Louis
18%
Transcription Factor
18%
Antiretroviral Therapy
18%
COVID-19 Pandemic
18%
Hospitalization
17%
CD8+ T Cells
17%
Central Nervous System
17%
Epitope
17%
Randomized Clinical Trial
17%
Lymphatic Filariasis
17%
Epidemiology
17%
Head-and-neck Cancer
17%
Meta-analysis
17%
Aging
16%
Vaccination
16%
Placebo
16%
Viral Infection
16%
Influenza Virus
15%
Natural Killer Cells
15%
Mouse Model
15%
Cardiovascular Disease
15%
Zika Virus
15%
Monocytes
15%
Missouri
15%
Vesicular Stomatitis Virus
15%
Innate Immune Response
15%
Viral
15%
Kidney
14%
Genome-wide Association Study
14%
Asthma
14%
Infectious Diseases
14%
B Cells
14%
Dengue Virus
14%
Quality of Life
14%
Hazard Ratio
14%
Late-life Depression
14%
Adjusted Odds Ratio
14%
Apoptosis
13%
HIV Patients
13%
Neutralizing Antibodies
13%
Flavivirus
13%
Staphylococcus Aureus
13%
Disease Severity
13%
Transplantation
13%
Acute Respiratory Distress Syndrome
12%
Depressive Symptoms
12%
Type 1 Diabetes Mellitus (T1DM)
12%
Cognitive Impairment
12%
Tuberculosis
12%
Surgical Site Infection
12%
Neutrophils
12%
Chikungunya Virus (CHIKV)
12%
Major Depressive Disorder
12%
Clinically Significant
12%
Mycobacterium Tuberculosis (M. tb)
12%
Mass Drug Administration
12%
Genotype
11%
Older Patients
11%
Human Immunodeficiency Virus Type 1 (HIV-1)
11%
Patients with Heart Failure
11%
Adverse Events
11%
Antibody Response
11%
Clostridium Difficile Infection
11%
Influenza
11%
Acute Rejection
11%
Medicine and Dentistry
Infection
77%
Diseases
73%
COVID-19
61%
Human Immunodeficiency Virus
46%
Severe Acute Respiratory Syndrome Coronavirus 2
42%
Pediatrics
40%
Lung Transplantation
34%
Congestive Heart Failure
34%
Alzheimer's Disease
34%
Lung
33%
Sepsis
31%
Odds Ratio
28%
Clinician
26%
Emergency Department
25%
Diagnosis
24%
Prevalence
24%
Clinical Trial
22%
Biological Marker
21%
Injury
21%
Intensive Care Unit
21%
Randomized Controlled Trial
21%
Comorbidity
19%
Malignant Neoplasm
18%
Virus
18%
Systematic Review
18%
Quality of Life
17%
Cohort Effect
17%
Health Care Cost
17%
Bleeding
16%
Pathogen
15%
Transplantation
15%
Hazard Ratio
14%
Placebo
14%
Cardiovascular Disease
14%
Cohort Analysis
14%
Randomized Clinical Trial
14%
Head and Neck Cancer
14%
Apoplexy
13%
Cerebrospinal Fluid
13%
Antibiotics
13%
Lymphatic Filariasis
13%
Logistic Regression Analysis
13%
Diabetes
13%
Diabetes Mellitus
13%
Adverse Event
13%
Immunity
12%
Health Care
12%
Infectious Disease
12%
Adolescence
12%
Meta-Analysis
12%
T Cell
12%
Observational Study
12%
Programmed Cell Death
12%
Surgical Infection
12%
Surgery
12%
Bloodstream Infection
12%
Virus Infection
12%
Messenger RNA
11%
Medicine
11%
Macrophage
11%
Neoplasm
11%
Cardiovascular System
11%
Intensive Care
11%
Allograft
11%
Amyloid Protein
11%
Antiinfective Agent
11%
Tertiary Care
11%
Receptor
11%
Antiretroviral Therapy
11%
Tau
11%
Mental Health
10%
Left Ventricular Assist Device
10%
Outpatient
9%
Asthma
9%
Platelet
9%
Magnetic Resonance Imaging
9%
Neuropathy
9%
Retrospective Cohort Study
9%
Drug Administration
9%
Public Health
9%
Immune Response
9%
Parkinson's Disease
8%
Gut
8%
Immunosuppressive Treatment
8%
Serositis
8%
In Vitro
8%
Gene Expression
8%
Acute Respiratory Distress Syndrome
8%
Central Nervous System
8%
Cancer
8%
Human Immunodeficiency Virus Infection
8%
Recurrent Disease
8%
Pediatrics Patient
8%
Cytomegalovirus
7%
Positron Emission Tomography
7%
Patient Care
7%
Venous Thromboembolism
7%
Overall Survival
7%
Combination Therapy
7%
Cross Sectional Study
7%